About the company

FabRx is a specialist biotech company, focused on developing 3D printing technology for fabricating pharmaceuticals and medical devices. 3D printing automates compounding and increases the personalisation options. It can also be used to reduce time and costs associated with clinical trial batch production. FabRx’s breakthrough 3D printer, M3DIMAKERTM, is the world’s first pharmaceutical 3D printer for personalised medicines.

Dr Alvaro Goyanes

CEO